Wendy Douglass

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))

P. Emery, Atul Deodhar, William F. C. Rigby et al. · Annals of the Rheumatic Diseases · 2010 · 345 citations · Full text

Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTA

Hisham Abdallah, Joy Hsu, Peng Lü et al. · The Journal of Clinical Pharmacology · 2016 · 94 citations · Full text

Immunology, Pharmacotherapy, Immunotherapy +16

Effect of Integrin β2 Subunit Truncations on LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) Assembly, Surface Expression, and Function

Suet‐Mien Tan, Robert H. Hyland, Aymen Al‐Shamkhani et al. · The Journal of Immunology · 2000 · 61 citations · Full text

Molecular characterization of leukocyte adhesion deficiency in six patients

Ann H. Wright, Wendy Douglass, G M Taylor et al. · European Journal of Immunology · 1995 · 42 citations

Efficacy and Safety of Tocilizumab for Polyarticular‐Course Juvenile Idiopathic Arthritis in the Open‐Label Two‐Year Extension of a Phase III Trial

Hermine I. Brunner, Nicolino Ruperto, Zbigniew Żuber et al. · Arthritis & Rheumatology · 2020 · 35 citations · Full text